BioCentury - Precision for pancreatic cancer
BioCentury,
Real-time sequencing and organoid-based screens in pancreatic cancer could place new targets and biomarkers in the hands of…
Real-time sequencing and organoid-based screens in pancreatic cancer could place new targets and biomarkers in the hands of…
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Lustgarten-Funded Research Impacting Patients in Real Time PR Newswire WOODBURY, N.Y., June 14, 2018 WOODBURY, N.Y., June 14…